ArticleHealth science reports2026
Understanding the Molecular Landscape of Alopecia Areata: Key Genes, Regulatory Networks, and Therapeutic Targets.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alopecia areata (AA) is an autoimmune disorder characterized by hair loss due to immune-mediated destruction of hair follicles. The polygenic nature of AA, influenced by genetic and environmental factors, complicates its pathogenesis. Advances in bioinformatics have facilitated understanding of AA's genetic basis, providing insights into key molecular pathways and regulatory mechanisms. Materials and Methods: This study utilized the GEO database (dataset GSE111061) to analyze differentially expressed genes (DEGs) between healthy controls and AA patients. Functional enrichment and protein-protein interaction (PPI) network analyzes identified hub genes, transcription factors (TFs), and miRNAs. Tools such as STRING, Cytoscape, and KEGG were employed to uncover key interactions and pathways. Results: An aggregate of 5134 DEGs was discovered, with 2576 elevated genes constituting a PPI network. Key pathways included chemokine signaling and cytokine-cytokine receptor interactions. Ten hub genes (e.g., CCL5, CCR7, and CXCL9) and top TFs (ZNF683, FOXP3, and TBX21) were identified. Additionally, 49 miRNAs were predicted to regulate AA-related genes. Conclusions: This work focuses on critical molecular regulators involved in AA pathogenesis, such as TFs and miRNAs. These findings suggest possible treatment targets and shed light on the molecular mechanisms of AA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.